• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [25125 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fundus photography for the diagnosis of diabetic retinopathy]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Local hyperbaric oxygen therapy for diabetic foot ulcers]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for the update of the DMP "Chronic obstructive pulmonary disease (COPD)]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Test quality: Evidence report for the S3 guideline on allergic rhinitis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [House dust mites: Evidence report for the S3 guideline on allergic rhinitis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pollen: Evidence report for the S3 guideline on allergic rhinitis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pets-rodents: Evidence report for the S3 guideline on allergic rhinitis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Flour: Evidence report for the S3 guideline on allergic rhinitis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Laboratory animals – farm animals: Evidence report for the S3 guideline on allergic rhinitis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of pelvic floor training during pregnancy for the prevention of pre and postnatal urinary incontinence]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Efficacy and safety of model-informed precision dosing of biologic agents]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Neurosurgical robot for electrode implantation, brain biopsies and spinal surgery]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Artificial intelligence software to detect viable tissue in stroke patients on CT or perfusion MRI of the skull]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Telemedicine for the follow-up of post-stroke patients]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of the safety, clinical and cost-effectiveness of neonatal screening for type 1 citrullinaemia, trifunctional protein deficiency, holocarboxyl synthetase deficiency, argininosuccinic aciduria and 3-methylcrotonyl-CoA carboxylase deficiency]
2026     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Safety, clinical effectiveness and cost-effectiveness of neonatal screening for Pompe disease]
2026     Belgian Health Care Knowledge Centre (KCE) Assessment of a mobile application in the rehabilitation of patients undergoing primary knee or hip arthroplasty (Study 2020-01)
2026     Belgian Health Care Knowledge Centre (KCE) Economic evaluation based on ‘PRECISe’, a randomised clinical trial funded by the KCE Trials programme (Study 2024-92)
2026     Health Information and Quality Authority (HIQA) Health technology assessment of RSV immunisation
2026     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Barriers and facilitators when implementing guidelines in health and social care for the elderly]
2026     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of Nirmatrelvir plus ritonavir (Paxlovid)]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Review of the lower age limit and frequency of early-detection colonoscopy in the colorectal cancer screening programme]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acupuncture for migraine prophylaxis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for metachromatic leukodystrophy]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a decision aid for carotid revascularization surgery for carotid stenosis]
2026     Swiss Federal Office of Public Health (FOPH) Valerian extracts for sleep disorders, anxiety or restlessness
2026     Swiss Federal Office of Public Health (FOPH) Ginkgo biloba in patients with decreasing mental performance, peripheral arterial occlusive disease, vertigo or tinnitus
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evaluation of the regulations governing a tiered system of emergency structures in hospitals]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Decision aid for prostate cancer]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Radiofrequency energy treatment for organic erectile dysfunction]
2026     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Lattice radiotherapy in the curative or palliative treatment of deep, large-volume tumors and metastatic or unresectable disease]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [X-ray image of the lung: Can artificial intelligence support the analysis of X-ray images?]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Quality of sleep: Can taking melatonin as a dietary supplement, e.g. in the form of tablets, sprays or soft gums, help to improve sleep?]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vulvodynia (itching and pain in the vulva area): What non-drug treatment options are promising?]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Adhesions in the abdominal cavity: Do other measures help to relieve symptoms instead of surgery?]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Revision of the information materials on colorectal cancer screening]
2026     Swiss Federal Office of Public Health (FOPH) Thermoablation for benign thyroid nodules
2026     Swiss Federal Office of Public Health (FOPH) Injection therapies with corticosteroids for chronic tendinopathy or enthesopathy
2026     Swiss Federal Office of Public Health (FOPH) Superficial/deep heat in physiotherapy for musculoskeletal conditions
2026     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Reinforced foster homes]
2026     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficacy and safety of emotional freedom techniques for the treatment of anxiety, depression and post traumatic stress disorders]
2025     Institute of Health Economics (IHE) Use of real world evidence to inform or augment reimbursement decisions
2025     Institute of Health Economics (IHE) Team-based primary care models: national and international approaches
2025     Institute of Health Economics (IHE) Indirect and direct non-medical costs in patients with type 2 diabetes
2025     Institute of Health Economics (IHE) Implementation of activity-based funding in acute care
2025     Institute of Health Economics (IHE) Hybrid closed loop insulin delivery systems for the treatment of diabetes
2025     Institute of Health Economics (IHE) Cost-effectiveness of antiviral drugs to prevent or treat influenza A, influenza B, or zoonotic influenza
2025     Institute of Health Economics (IHE) Comparing the use of artificial intelligence to traditional methods for study selection and data extraction in a rapid review
2025     Institute of Health Economics (IHE) Antiviral drugs for the prevention or treatment of zoonotic influenza
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Effectiveness and efficiency evaluation of neonatal screening for X-linked adrenoleukodystrophy]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Thermotest for the assessment of small fibre neuropathy]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Effectiveness of electrical impedance tomography in the management of critical patients with acute respiratory distress syndrome, treated with mechanical ventilation]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Effectiveness and safety of an absorbable nasal implant for the treatment of nasal obstruction caused by nasal valve collapse]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Effectiveness and safety of radiofrequency nucleolysis for chronic or acute low back pain]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Diagnostic effectiveness of rapid immunochromatographic tests for the detection of Campylobacter spp. and Salmonella spp. in patients with acute gastroenteritis]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Efficacy and safety of selective posterior nasal nerve cryosurgery for the symptomatic treatment of chronic rhinosinusitis]
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Effectiveness, safety, and cost-effectiveness of prenatal serological screening for cytomegalovirus]
2025     Agency for Healthcare Research and Quality (AHRQ) Updating the framework for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report
2025     Agency for Healthcare Research and Quality (AHRQ) Trauma informed care: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Supply chain disruption monitoring programs
2025     Agency for Healthcare Research and Quality (AHRQ) Psychosocial and pharmacologic interventions for disruptive behavior in children and adolescents
2025     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic and nonpharmacologic treatments for posttraumatic stress disorder: an update of the PTSD trials standardized repository
2025     Agency for Healthcare Research and Quality (AHRQ) Peripheral nerve blocks for postoperative pain management in cardiothoracic surgery: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Pediatric Quality Measures Program 3.0: an evidence map of measures for vision, hearing, and developmental screening and followup
2025     Agency for Healthcare Research and Quality (AHRQ) Misuse of ADHD prescription stimulants in adults
2025     Agency for Healthcare Research and Quality (AHRQ) Mental health and occupational stress in the emergency medical services and 911 workforces
2025     Agency for Healthcare Research and Quality (AHRQ) Measure criteria for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report
2025     Agency for Healthcare Research and Quality (AHRQ) Management of suicidal thoughts and behaviors in youth: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Making healthcare safer IV: use of structured handoff protocols for intrahospital within-unit transitions
2025     Agency for Healthcare Research and Quality (AHRQ) Making healthcare safer IV: programs for responding to harms experienced by patients during clinical care
2025     Agency for Healthcare Research and Quality (AHRQ) Living systematic review on cannabis and other plant-based treatments for chronic pain
2025     Agency for Healthcare Research and Quality (AHRQ) Interventions to prevent nonventilator hospital-acquired pneumonia
2025     Agency for Healthcare Research and Quality (AHRQ) Interventions to improve care of bereaved persons
2025     Agency for Healthcare Research and Quality (AHRQ) Implementing recommended mental health and substance use screening and counseling interventions in primary care settings for children and adolescents
2025     Agency for Healthcare Research and Quality (AHRQ) Fiber intake and laxation in people with normal bowel function
2025     Agency for Healthcare Research and Quality (AHRQ) Examining the impact of implementing high-reliability organization principles on patient safety outcomes
2025     Agency for Healthcare Research and Quality (AHRQ) Digestible carbohydrate intake and maternal-infant outcomes: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of medical therapies for locally advanced gastric adenocarcinoma
2025     Agency for Healthcare Research and Quality (AHRQ) Breastfeeding and health outcomes for infants and children
2025     Agency for Healthcare Research and Quality (AHRQ) Blood-based tests for multiple cancer screening: a systematic review
2025     Agency for Healthcare Research and Quality (AHRQ) Association of digestible carbohydrate intake with cardiovascular disease, type 2 diabetes, obesity, and body composition
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people with substance use disorder: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people receiving treatments that cause medication-related osteonecrosis of the jaw: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people receiving treatment for human immunodeficiency virus: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Association between outcomes and dental services in people at risk of post-transplant complications: a rapid response review
2025     Agency for Healthcare Research and Quality (AHRQ) Assisted home dialysis in the United States: new interest in an old idea
2025     Agency for Healthcare Research and Quality (AHRQ) Acute care nursing staff shortages that compromise patient-to-nurse ratios
2025     Austrian Institute for Health Technology Assessment (AIHTA) Long-term effectiveness and safety of enzyme replacement therapy in mucopolysaccharidosis type I, II, IVA and Pompe disease: a systematic review
2025     Austrian Institute for Health Technology Assessment (AIHTA) Dorocubicel + unexpanded CD34– cells (Zemcelpro®) for the treatment of haematological malignancies in adults
2025     WorkSafeBC Effect of ropinirole on patients with myoclonic dystonia: 2025 update
2025     WorkSafeBC Osteoarthritis of the knee and foot orthoses
2025     WorkSafeBC Cervical disc herniation and cervical spine degeneration
2025     WorkSafeBC COVID-19 vaccine and systemic lupus erythematosus (SLE)
2025     WorkSafeBC Use of supplements to treat patients diagnosed with sciatica
2025     WorkSafeBC Firefighting and Hodgkins lymphoma
2025     WorkSafeBC Hypertension and firefighting
2025     WorkSafeBC Platelet rich plasma (PRP) in treating post-fracture ankle pain
2025     WorkSafeBC External trigeminal nerve stimulation (e-TNS) in treating and preventing migraine headaches
2025     Agency for Care Effectiveness (ACE) Toripalimab for first-line systemic treatment of recurrent or metastatic nasopharyngeal carcinoma
2025     Agency for Care Effectiveness (ACE) Momelotinib for treating myelofibrosis in patients with moderate to severe anaemia